The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Drug Monitoring Market Research Report 2025
Synopsis
The global market for Therapeutic Drug Monitoring was valued at US$ 2145 million in the year 2024 and is projected to reach a revised size of US$ 3841 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs. Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The Therapeutic Drug Monitoring (TDM) market is growing due to an increasing focus on personalized medicine, which tailors treatments to the individual characteristics of each patient. TDM enables clinicians to optimize drug dosages for better efficacy and reduced toxicity, particularly important for drugs with narrow therapeutic windows, such as immunosuppressants, anti-epileptics, and certain antibiotics. As the incidence of chronic diseases rises globally, there is greater demand for precise dosing in treatments, which supports TDM's expanding role. Additionally, technological advancements in laboratory automation and assay sensitivity are making TDM more accessible and accurate, further driving market growth.
A significant challenge in the TDM market is the high cost of testing and the need for specialized equipment and expertise, which can limit its accessibility, especially in lower-income regions. TDM requires sophisticated instruments and skilled personnel to interpret results accurately, leading to a barrier for healthcare facilities without sufficient resources. Furthermore, in some cases, there is a lack of standardized protocols for monitoring certain drugs, creating inconsistencies in practices across healthcare systems. These factors may hinder the widespread adoption of TDM, especially in resource-constrained settings.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45%.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring.
The Therapeutic Drug Monitoring market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical
DAT Diagnostic
Chromai
Segment by Type
Blood Test
Urine Test
Saliva Test
Segment by Application
Hospital Labs
Independent Clinical Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Therapeutic Drug Monitoring was valued at US$ 2145 million in the year 2024 and is projected to reach a revised size of US$ 3841 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs. Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The Therapeutic Drug Monitoring (TDM) market is growing due to an increasing focus on personalized medicine, which tailors treatments to the individual characteristics of each patient. TDM enables clinicians to optimize drug dosages for better efficacy and reduced toxicity, particularly important for drugs with narrow therapeutic windows, such as immunosuppressants, anti-epileptics, and certain antibiotics. As the incidence of chronic diseases rises globally, there is greater demand for precise dosing in treatments, which supports TDM's expanding role. Additionally, technological advancements in laboratory automation and assay sensitivity are making TDM more accessible and accurate, further driving market growth.
A significant challenge in the TDM market is the high cost of testing and the need for specialized equipment and expertise, which can limit its accessibility, especially in lower-income regions. TDM requires sophisticated instruments and skilled personnel to interpret results accurately, leading to a barrier for healthcare facilities without sufficient resources. Furthermore, in some cases, there is a lack of standardized protocols for monitoring certain drugs, creating inconsistencies in practices across healthcare systems. These factors may hinder the widespread adoption of TDM, especially in resource-constrained settings.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45%.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring.
The Therapeutic Drug Monitoring market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical
DAT Diagnostic
Chromai
Segment by Type
Blood Test
Urine Test
Saliva Test
Segment by Application
Hospital Labs
Independent Clinical Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Labs
1.3.3 Independent Clinical Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Drug Monitoring Market Perspective (2020-2031)
2.2 Global Therapeutic Drug Monitoring Growth Trends by Region
2.2.1 Global Therapeutic Drug Monitoring Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Therapeutic Drug Monitoring Historic Market Size by Region (2020-2025)
2.2.3 Therapeutic Drug Monitoring Forecasted Market Size by Region (2026-2031)
2.3 Therapeutic Drug Monitoring Market Dynamics
2.3.1 Therapeutic Drug Monitoring Industry Trends
2.3.2 Therapeutic Drug Monitoring Market Drivers
2.3.3 Therapeutic Drug Monitoring Market Challenges
2.3.4 Therapeutic Drug Monitoring Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Drug Monitoring Players by Revenue
3.1.1 Global Top Therapeutic Drug Monitoring Players by Revenue (2020-2025)
3.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2020-2025)
3.2 Global Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Therapeutic Drug Monitoring Revenue
3.4 Global Therapeutic Drug Monitoring Market Concentration Ratio
3.4.1 Global Therapeutic Drug Monitoring Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring Revenue in 2024
3.5 Global Key Players of Therapeutic Drug Monitoring Head office and Area Served
3.6 Global Key Players of Therapeutic Drug Monitoring, Product and Application
3.7 Global Key Players of Therapeutic Drug Monitoring, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Drug Monitoring Breakdown Data by Type
4.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2020-2025)
4.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2026-2031)
5 Therapeutic Drug Monitoring Breakdown Data by Application
5.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2020-2025)
5.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Therapeutic Drug Monitoring Market Size (2020-2031)
6.2 North America Therapeutic Drug Monitoring Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Therapeutic Drug Monitoring Market Size by Country (2020-2025)
6.4 North America Therapeutic Drug Monitoring Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Drug Monitoring Market Size (2020-2031)
7.2 Europe Therapeutic Drug Monitoring Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Therapeutic Drug Monitoring Market Size by Country (2020-2025)
7.4 Europe Therapeutic Drug Monitoring Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring Market Size (2020-2031)
8.2 Asia-Pacific Therapeutic Drug Monitoring Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2020-2025)
8.4 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Drug Monitoring Market Size (2020-2031)
9.2 Latin America Therapeutic Drug Monitoring Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Therapeutic Drug Monitoring Market Size by Country (2020-2025)
9.4 Latin America Therapeutic Drug Monitoring Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring Market Size (2020-2031)
10.2 Middle East & Africa Therapeutic Drug Monitoring Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2020-2025)
10.4 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Therapeutic Drug Monitoring Introduction
11.1.4 Roche Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Therapeutic Drug Monitoring Introduction
11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.2.5 Danaher Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Therapeutic Drug Monitoring Introduction
11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Introduction
11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Details
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Therapeutic Drug Monitoring Introduction
11.5.4 Siemens Healthineers Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.5.5 Siemens Healthineers Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Introduction
11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 bioMerieux
11.7.1 bioMerieux Company Details
11.7.2 bioMerieux Business Overview
11.7.3 bioMerieux Therapeutic Drug Monitoring Introduction
11.7.4 bioMerieux Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.7.5 bioMerieux Recent Development
11.8 Bühlmann Laboratories
11.8.1 Bühlmann Laboratories Company Details
11.8.2 Bühlmann Laboratories Business Overview
11.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring Introduction
11.8.4 Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.8.5 Bühlmann Laboratories Recent Development
11.9 Randox Laboratories
11.9.1 Randox Laboratories Company Details
11.9.2 Randox Laboratories Business Overview
11.9.3 Randox Laboratories Therapeutic Drug Monitoring Introduction
11.9.4 Randox Laboratories Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.9.5 Randox Laboratories Recent Development
11.10 Sekisui Medical
11.10.1 Sekisui Medical Company Details
11.10.2 Sekisui Medical Business Overview
11.10.3 Sekisui Medical Therapeutic Drug Monitoring Introduction
11.10.4 Sekisui Medical Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.10.5 Sekisui Medical Recent Development
11.11 DAT Diagnostic
11.11.1 DAT Diagnostic Company Details
11.11.2 DAT Diagnostic Business Overview
11.11.3 DAT Diagnostic Therapeutic Drug Monitoring Introduction
11.11.4 DAT Diagnostic Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.11.5 DAT Diagnostic Recent Development
11.12 Chromai
11.12.1 Chromai Company Details
11.12.2 Chromai Business Overview
11.12.3 Chromai Therapeutic Drug Monitoring Introduction
11.12.4 Chromai Revenue in Therapeutic Drug Monitoring Business (2020-2025)
11.12.5 Chromai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Test
Table 3. Key Players of Urine Test
Table 4. Key Players of Saliva Test
Table 5. Global Therapeutic Drug Monitoring Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Therapeutic Drug Monitoring Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Therapeutic Drug Monitoring Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Therapeutic Drug Monitoring Market Share by Region (2020-2025)
Table 9. Global Therapeutic Drug Monitoring Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Therapeutic Drug Monitoring Market Share by Region (2026-2031)
Table 11. Therapeutic Drug Monitoring Market Trends
Table 12. Therapeutic Drug Monitoring Market Drivers
Table 13. Therapeutic Drug Monitoring Market Challenges
Table 14. Therapeutic Drug Monitoring Market Restraints
Table 15. Global Therapeutic Drug Monitoring Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Therapeutic Drug Monitoring Market Share by Players (2020-2025)
Table 17. Global Top Therapeutic Drug Monitoring Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring as of 2024)
Table 18. Ranking of Global Top Therapeutic Drug Monitoring Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Therapeutic Drug Monitoring Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Therapeutic Drug Monitoring, Headquarters and Area Served
Table 21. Global Key Players of Therapeutic Drug Monitoring, Product and Application
Table 22. Global Key Players of Therapeutic Drug Monitoring, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Therapeutic Drug Monitoring Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
Table 26. Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2026-2031)
Table 28. Global Therapeutic Drug Monitoring Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
Table 30. Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2026-2031)
Table 32. North America Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Therapeutic Drug Monitoring Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Therapeutic Drug Monitoring Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Therapeutic Drug Monitoring Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Therapeutic Drug Monitoring Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Therapeutic Drug Monitoring Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Therapeutic Drug Monitoring Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Therapeutic Drug Monitoring Product
Table 50. Roche Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Danaher Company Details
Table 53. Danaher Business Overview
Table 54. Danaher Therapeutic Drug Monitoring Product
Table 55. Danaher Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 56. Danaher Recent Development
Table 57. Abbott Company Details
Table 58. Abbott Business Overview
Table 59. Abbott Therapeutic Drug Monitoring Product
Table 60. Abbott Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Therapeutic Drug Monitoring Product
Table 65. Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Siemens Healthineers Company Details
Table 68. Siemens Healthineers Business Overview
Table 69. Siemens Healthineers Therapeutic Drug Monitoring Product
Table 70. Siemens Healthineers Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 71. Siemens Healthineers Recent Development
Table 72. Bio-Rad Laboratories Company Details
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Therapeutic Drug Monitoring Product
Table 75. Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Development
Table 77. bioMerieux Company Details
Table 78. bioMerieux Business Overview
Table 79. bioMerieux Therapeutic Drug Monitoring Product
Table 80. bioMerieux Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 81. bioMerieux Recent Development
Table 82. Bühlmann Laboratories Company Details
Table 83. Bühlmann Laboratories Business Overview
Table 84. Bühlmann Laboratories Therapeutic Drug Monitoring Product
Table 85. Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 86. Bühlmann Laboratories Recent Development
Table 87. Randox Laboratories Company Details
Table 88. Randox Laboratories Business Overview
Table 89. Randox Laboratories Therapeutic Drug Monitoring Product
Table 90. Randox Laboratories Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 91. Randox Laboratories Recent Development
Table 92. Sekisui Medical Company Details
Table 93. Sekisui Medical Business Overview
Table 94. Sekisui Medical Therapeutic Drug Monitoring Product
Table 95. Sekisui Medical Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 96. Sekisui Medical Recent Development
Table 97. DAT Diagnostic Company Details
Table 98. DAT Diagnostic Business Overview
Table 99. DAT Diagnostic Therapeutic Drug Monitoring Product
Table 100. DAT Diagnostic Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 101. DAT Diagnostic Recent Development
Table 102. Chromai Company Details
Table 103. Chromai Business Overview
Table 104. Chromai Therapeutic Drug Monitoring Product
Table 105. Chromai Revenue in Therapeutic Drug Monitoring Business (2020-2025) & (US$ Million)
Table 106. Chromai Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Therapeutic Drug Monitoring Picture
Figure 2. Global Therapeutic Drug Monitoring Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Therapeutic Drug Monitoring Market Share by Type: 2024 VS 2031
Figure 4. Blood Test Features
Figure 5. Urine Test Features
Figure 6. Saliva Test Features
Figure 7. Global Therapeutic Drug Monitoring Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Therapeutic Drug Monitoring Market Share by Application: 2024 VS 2031
Figure 9. Hospital Labs Case Studies
Figure 10. Independent Clinical Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Therapeutic Drug Monitoring Report Years Considered
Figure 13. Global Therapeutic Drug Monitoring Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Therapeutic Drug Monitoring Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Therapeutic Drug Monitoring Market Share by Region: 2024 VS 2031
Figure 16. Global Therapeutic Drug Monitoring Market Share by Players in 2024
Figure 17. Global Top Therapeutic Drug Monitoring Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Drug Monitoring Revenue in 2024
Figure 19. North America Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Therapeutic Drug Monitoring Market Share by Country (2020-2031)
Figure 21. United States Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Therapeutic Drug Monitoring Market Share by Country (2020-2031)
Figure 25. Germany Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Therapeutic Drug Monitoring Market Share by Region (2020-2031)
Figure 33. China Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Therapeutic Drug Monitoring Market Share by Country (2020-2031)
Figure 41. Mexico Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2020-2031)
Figure 45. Turkey Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Therapeutic Drug Monitoring Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 49. Danaher Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 52. Siemens Healthineers Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 54. bioMerieux Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 55. Bühlmann Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 56. Randox Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 57. Sekisui Medical Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 58. DAT Diagnostic Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 59. Chromai Revenue Growth Rate in Therapeutic Drug Monitoring Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
